• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴隐亭抑制去甲肾上腺素的释放。

Bromocriptine inhibits norepinephrine release.

作者信息

Ziegler M G, Lake C R, Williams A C, Teychenne P F, Shoulson I, Steinsland O

出版信息

Clin Pharmacol Ther. 1979 Feb;25(2):137-42. doi: 10.1002/cpt1979252137.

DOI:10.1002/cpt1979252137
PMID:759066
Abstract

Bromocriptine is a dopamine agonist that induces postural hypotension and can be used as an antihypertensive. The drug inhibits release of norepinephrine (NE) from an isolated artery by stimulating presynaptic receptors. In normotensive subjects it lowers both plasma and cerebrospinal fluid (CSF) levels of NE by 50% and lowers blood pressure moderately in standing subjects and slightly in recumbent subjects. Through central and peripheral mechanisms, bromocriptine inhibits sympathetic nervous discharge of NE.

摘要

溴隐亭是一种多巴胺激动剂,可引起体位性低血压,可用作抗高血压药。该药物通过刺激突触前受体抑制离体动脉去甲肾上腺素(NE)的释放。在血压正常的受试者中,它可使血浆和脑脊液(CSF)中的NE水平均降低50%,使站立受试者的血压适度降低,使卧位受试者的血压轻度降低。通过中枢和外周机制,溴隐亭抑制NE的交感神经释放。

相似文献

1
Bromocriptine inhibits norepinephrine release.溴隐亭抑制去甲肾上腺素的释放。
Clin Pharmacol Ther. 1979 Feb;25(2):137-42. doi: 10.1002/cpt1979252137.
2
The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation.多巴胺激动剂溴隐亭通过静脉和小动脉扩张诱导低血压。
J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):582-7. doi: 10.1097/00005344-198407000-00005.
3
Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.多巴胺和溴隐亭对家兔血压影响中的神经元及节后成分
J Pharmacol Exp Ther. 1985 Sep;234(3):681-90.
4
Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function.溴隐亭对血压及交感神经功能影响的分析
Eur J Pharmacol. 1979 Jun 15;56(3):253-6. doi: 10.1016/0014-2999(79)90178-x.
5
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.多巴胺激动剂对人体心血管系统和交感神经系统的影响。
Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23(4):175-9.
6
Purinergic facilitation of norepinephrine release from adrenergic nerves of rabbit ear artery.嘌呤能促进去甲肾上腺素从兔耳动脉肾上腺素能神经释放。
Proc West Pharmacol Soc. 1993;36:17-20.
7
Effects of bromocriptine on plasma catecholamines in normal men.溴隐亭对正常男性血浆儿茶酚胺的影响。
Neuroendocrinology. 1979;28(6):425-34. doi: 10.1159/000122891.
8
Dopamine and sympathoadrenal activity in man.
Clin Exp Hypertens. 1997 Jan-Feb;19(1-2):163-79. doi: 10.3109/10641969709080813.
9
Effects of sevoflurane on sympathetic neurotransmission in human omental arteries and veins.七氟醚对人网膜动静脉交感神经传递的影响。
Br J Anaesth. 2003 Jun;90(6):766-73. doi: 10.1093/bja/aeg135.
10
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
J Clin Endocrinol Metab. 1984 Jul;59(1):74-8. doi: 10.1210/jcem-59-1-74.

引用本文的文献

1
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.大脑多巴胺-时钟相互作用调节心脏代谢生理学:观察到的 2 型糖尿病患者中昼夜节律定时溴隐亭-QR 治疗的心脏保护作用的机制。
Int J Mol Sci. 2023 Aug 26;24(17):13255. doi: 10.3390/ijms241713255.
2
Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.昼夜定时速释溴隐亭可降低2型糖尿病患者静息心率升高的情况。
Endocrinol Diabetes Metab. 2019 Nov 13;3(1):e00101. doi: 10.1002/edm2.101. eCollection 2020 Jan.
3
Effects of dopamine on leptin release and leptin gene (OB) expression in adipocytes from obese and hypertensive patients.
多巴胺对肥胖和高血压患者脂肪细胞中瘦素释放及瘦素基因(OB)表达的影响。
Int J Nephrol Renovasc Dis. 2013 Nov 27;6:259-68. doi: 10.2147/IJNRD.S50664. eCollection 2013.
4
Stimulation of sympathetic activity by carbon dioxide in patients with autonomic failure compared to normal subjects.与正常受试者相比,自主神经功能衰竭患者中二氧化碳对交感神经活动的刺激作用。
Clin Auton Res. 1997 Dec;7(6):327-32. doi: 10.1007/BF02267726.
5
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.帕金森病早期使用溴隐亭可抑制左旋多巴相关运动副作用的出现。PRADO研究的长期结果。
J Neural Transm (Vienna). 1996;103(6):699-715. doi: 10.1007/BF01271230.
6
Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men.多巴胺能机制对卧位男性催乳素、促黄体生成素和睾酮24小时分泌模式的影响。
J Endocrinol Invest. 1983 Feb;6(1):9-15. doi: 10.1007/BF03350554.
7
Hemodynamic alterations produced by N,N-Di-n-propyldopamine in anesthetized dogs.N,N-二正丙基多巴胺对麻醉犬血流动力学的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):63-9. doi: 10.1007/BF00586351.
8
Increased forearm vascular resistance after dopamine blockade.多巴胺阻断后前臂血管阻力增加。
Br J Clin Pharmacol. 1984 Apr;17(4):373-8. doi: 10.1111/j.1365-2125.1984.tb02360.x.
9
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.帕金森病中的DL-3,4-苏式二羟基苯丝氨酸:对体位性低血压和头晕的影响
J Neural Transm. 1983;58(3-4):305-13. doi: 10.1007/BF01252816.
10
Effect of bromocriptine on plasma catecholamines in normal subjects and prolactin-secreting tumor patients.
J Endocrinol Invest. 1986 Jun;9(3):223-6. doi: 10.1007/BF03348104.